Skip to main content
. 2017 Apr 17;12(4):e0175828. doi: 10.1371/journal.pone.0175828

Table 1. Clinical characteristics of IgAN patients with CKD stage 3 with different eGFR (mL/min/per 1.73m2).

Characteristics 55 to < 60
(n = 70)
50 to <55
(n = 77)
45 to < 50
(n = 63)
40 to < 45
(n = 67)
35 to < 40
(n = 58)
30 to < 35
(n = 55)
P value
Sex(male/femal) 46/24 57/20 41/22 47/20 41/17 32/23 0.489
Age (yr) 36.94±11.67 41.70±11.79 39.52±13.05 40.66±12.85 44.93±13.50 36.73±12.32 0.003*
SBP (mmHg) 129.80±18.78 135.61±17.41 135.57±16.47 132.94±17.29 136.21±16.34 137.38±17.94 0.146
DBP (mmHg) 83.39±13.89 87.52±11.86 83.40±11.55 85.67±14.25 86.76±11.99 88.69±10.48 0.086
Hemoglobin (g/L) 129.85± 19.23 134.04 ± 22.27 123.63±21.71 128.47±22.39 113.96±19.85 120.76±27.02 < 0.001*
Serum uric acid (umol/L) 393.43± 85.74 434.00± 103.68 407.13± 112.47 456.97± 133.25 455.12± 118.36 459.53± 119.01 0.001*
Scr (umol/L) 128.19± 27.98 137.77± 20.76 146.65± 25.34 164.10± 31.85 179.19± 32.31 208.02± 46.29 < 0.001*
Serum urea nitrogen (mmol/L) 7.74±2.81 8.04± 3.18 8.72± 3.40 10.51± 3.75 10.40± 3.33 12.21± 5.00 < 0.001*
eGFR(mL/min/per 1.73m2) 57.69±1.64 52.64±1.35 47.27±1.41 42.48±1.42 37.67±1.38 32.34±1.39 < 0.001*
Serum albumin (g/L) 35.43±6.68 37.81±6.24 41.72±52.00 34.80±8.35 36.16±6.86 35.49±6.44 0.49
Serum cholesterol (mmol/L) 5.43±1.89 4.84±1.25 5.12±1.82 4.90±1.34 5.31±2.15 4.84±1.35 0.179
Serum triglyceride(mmol/L) 1.94±1.65 1.99±1.52 1.81±1.68 2.62±2.17 1.99±1.20 1.99±1.10 0.076
Serum calcium (mmol/L) 2.23 ± 0.13 2.27 ± 0.14 2.19±0.17 2.20±0.16 2.22±0.21 2.24±0.17 0.078
Serum phosphorus (mmol/L) 1.24 ± 0.25 1.22 ± 0.23 1.27±0.22 1.33±0.38 1.28±0.25 1.48±0.27 < 0.001*
Proteinuria of 24-hour (g) 1.82(3.51,6.16) 1.60(2.60,5.34) 2.05(4.07,7.13) 2.08(3.52,5.26) 2.50(4.93,5.91) 1.96(4.29,6.26) 0.677

*P<0.05.

Abbreviations: IgAN, IgA nephropathy; CKD, chronic kidney disease; eGFR, estimated glomerular filtration rate; SBP, systolic blood pressure; DBP, diastolic blood pressure; Scr, serum creatinine.